The Union Budget is making a significant investment in India's health and innovation. Biopharma has been identified as a key strategic sector. A new initiative, 'Biopharma Shakti', will receive Rs 10,000 crore over five years. This funding will boost manufacturing, regulation, and clinical trials. The aim is to establish India as a global biopharma manufacturing hub.
